Advertisement

Topics

Head to Head Survey: DARA Biosciences

20:42 EST 12 Nov 2017 | Topix

DARA Biosciences and Mallinckrodt PLC are both specialty & advanced pharmaceuticals companies, but which is the superior investment? We will contrast the two companies based on the strength of their analyst recommendations, profitability, risk, institutional ownership, dividends, valuation and earnings. DARA Biosciences has a beta of 0.72, indicating that its share price is 28% less volatile than the S&P 500.

Original Article: Head to Head Survey: DARA Biosciences

NEXT ARTICLE

More From BioPortfolio on "Head to Head Survey: DARA Biosciences"

Advertisement
Quick Search
Advertisement
Advertisement